484 related articles for article (PubMed ID: 11374025)
21. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.
Ricote M; Li AC; Willson TM; Kelly CJ; Glass CK
Nature; 1998 Jan; 391(6662):79-82. PubMed ID: 9422508
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
Touyz RM; Schiffrin EL
Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
[TBL] [Abstract][Full Text] [Related]
23. Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis.
Barbier O; Torra IP; Duguay Y; Blanquart C; Fruchart JC; Glineur C; Staels B
Arterioscler Thromb Vasc Biol; 2002 May; 22(5):717-26. PubMed ID: 12006382
[TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptors in endothelial cell biology.
Plutzky J
Curr Opin Lipidol; 2001 Oct; 12(5):511-8. PubMed ID: 11561170
[TBL] [Abstract][Full Text] [Related]
25. [Peroxisome proliferator activated nuclear receptors: possible role in the development of atherosclerosis].
Evdokimova MA; Zateĭshchikov DA; Sidorenko BA
Kardiologiia; 2003; 43(11):41-8. PubMed ID: 14671562
[TBL] [Abstract][Full Text] [Related]
26. The role of PPARs in atherosclerosis.
Duval C; Chinetti G; Trottein F; Fruchart JC; Staels B
Trends Mol Med; 2002 Sep; 8(9):422-30. PubMed ID: 12223313
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway.
Delerive P; Martin-Nizard F; Chinetti G; Trottein F; Fruchart JC; Najib J; Duriez P; Staels B
Circ Res; 1999 Sep; 85(5):394-402. PubMed ID: 10473669
[TBL] [Abstract][Full Text] [Related]
28. The effects of fibrates and thiazolidinediones on plasma triglyceride metabolism are mediated by distinct peroxisome proliferator activated receptors (PPARs).
Staels B; Schoonjans K; Fruchart JC; Auwerx J
Biochimie; 1997; 79(2-3):95-9. PubMed ID: 9209702
[TBL] [Abstract][Full Text] [Related]
29. Clinical interest of PPARs ligands.
Vergès B
Diabetes Metab; 2004 Feb; 30(1):7-12. PubMed ID: 15029092
[TBL] [Abstract][Full Text] [Related]
30. Peroxisome proliferator-activated receptors in the cardiovascular system.
Bishop-Bailey D
Br J Pharmacol; 2000 Mar; 129(5):823-34. PubMed ID: 10696077
[TBL] [Abstract][Full Text] [Related]
31. Roles of peroxisome proliferator-activated receptor gamma in cardiovascular disease.
Takano H; Komuro I
J Diabetes Complications; 2002; 16(1):108-14. PubMed ID: 11872377
[TBL] [Abstract][Full Text] [Related]
32. Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.
Staels B; Koenig W; Habib A; Merval R; Lebret M; Torra IP; Delerive P; Fadel A; Chinetti G; Fruchart JC; Najib J; Maclouf J; Tedgui A
Nature; 1998 Jun; 393(6687):790-3. PubMed ID: 9655393
[TBL] [Abstract][Full Text] [Related]
33. Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease.
Guan Y
Minerva Urol Nefrol; 2002 Jun; 54(2):65-79. PubMed ID: 12185990
[TBL] [Abstract][Full Text] [Related]
34. Peroxisome proliferator-activated receptors (PPARs) and their role in the vessel wall: possible mediators of cardiovascular risk?
Marx N; Libby P; Plutzky J
J Cardiovasc Risk; 2001 Aug; 8(4):203-10. PubMed ID: 11550998
[TBL] [Abstract][Full Text] [Related]
35. The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signalling.
Desvergne B; IJpenberg A; Devchand PR; Wahli W
J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):65-74. PubMed ID: 9699859
[TBL] [Abstract][Full Text] [Related]
36. PPARS, metabolic disease and atherosclerosis.
Fruchart JC; Staels B; Duriez P
Pharmacol Res; 2001 Nov; 44(5):345-52. PubMed ID: 11712864
[TBL] [Abstract][Full Text] [Related]
37. Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor gamma: implications for cardiovascular disease.
Tontonoz P; Nagy L
Curr Opin Lipidol; 1999 Dec; 10(6):485-90. PubMed ID: 10680041
[TBL] [Abstract][Full Text] [Related]
38. Peroxisome proliferator-activated receptors in macrophage biology: friend or foe?
Moore KJ; Fitzgerald ML; Freeman MW
Curr Opin Lipidol; 2001 Oct; 12(5):519-27. PubMed ID: 11561171
[TBL] [Abstract][Full Text] [Related]
39. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages.
Chinetti G; Griglio S; Antonucci M; Torra IP; Delerive P; Majd Z; Fruchart JC; Chapman J; Najib J; Staels B
J Biol Chem; 1998 Oct; 273(40):25573-80. PubMed ID: 9748221
[TBL] [Abstract][Full Text] [Related]
40. [New concepts on the mechanism of action of fibrates and therapeutic prospectives in atherosclerosis].
Fruchart JC; Staels B; Duriez P
Bull Acad Natl Med; 2001; 185(1):63-74; discussion 74-5. PubMed ID: 11474570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
